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UK inquiry opened into human trials of biological and chemical weapons
UK police are investigating allega-tions made by a former Royal Air
Force (RAF) serviceman that experi-
ments at Porton Down Chemical and
Biological Defence Establishment in
which he participated left him with a
long-term debilitating illness.
Gordon Bell attributes his injuries
directly to the experiments, and is
reported to have welcomed the
Wiltshire Police’s decision to investi-
gate his claims.
Bell is also reported to have 
uncovered evidence of the death of a
RAF colleague, 20-year-old Ronald
Maddison, on May 6, 1953, during a
trial with sarin. It is claimed that
Maddison, who had respiratory 
protection throughout the trial, had
200 mg of sarin dripped onto two lay-
ers of clothing on his forearm.
In an interview on the BBC’s T o d a y
radio programme on Aug 20, the tech-
nical director at Porton Down, Rick
Hall said that “the death was subject
to a coroner’s inquest at the time and
also to the court of inquiry by the
Ministry of Supply . . . . Although
these documents have not been pub-
lished, the essential details of the
death have appeared in the press many
times since 1953”.
Hall denied that the UK was still
involved in developing chemical
weapons, and stated that volunteers
currently helping at Porton Down
knew what they were volunteering for.
Bell has claimed he did not know 
that the tests he was involved in dur-
ing the 1950s were part of chemical
and biological warfare experiments.
Michael Roach, chairman of the
Porton Down Volunteers Association,
and a former Royal Engineer, was also
involved in human trials at Porton
Down: “The first time I was exposed
to mustard gas, and the second time
was nerve gas which I inhaled directly
into the lungs”. Roach says he know-
ingly volunteered for trials at Porton
Down in 1962 and 1963 “out of a
sense of patriotism”—only 2–3% of
his association claim to have thought
the tests they were involved in were for
the common cold.
But Roach says “we were told to
expect minor temporary discomfort.
Never was it once mentioned to any-
body or put in writing . . . that there
would be any possibility of long-term
health effects. I haven’t worked for 10
years because of breathing problems”,
he added.
In a statement the Ministry of
Defence said they “will offer every
assistance to the investigation and
open all archive material to the
Wiltshire Police”.
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New Zealand court allows national blood samples to be used in civil trial
Apaternity case in New Zealandhas raised controversy about a
little-known national bank of 
heel-prick blood samples collected
from all newborn infants since 1969.
The tests check for seven disorders
and are then stored at the National
Testing Centre (NTC) in Auckland. 
The controversy surrounds the
use of the stored tests in a civil
c a s e—the first time this has been
permitted. In the case, the baby had
died and the mother did not want
the results of a DNA blood
t e s t—which proved paternity—to be
used in the court. The blood test had
been approved by a High Court
order, but the women said that she
had not known her baby’s blood was
being stored and never gave her 
consent for this to happen.
In the High Court, Justice Morris
rejected arguments from the lawyer
acting for the baby’s mother that to
allow the evidence to be admitted in
the case would be contrary to public
policy and would set a dangerous
precedent. Instead, Justice Morris
described the case as being “strictly
between the parties”.
Currently, New Zealand police
have legal access to the national
bank’s blood tests for criminal
cases. In a current murder trial,
DNA from the stored blood of one 
of the murder victims—whose 
bodies were never found—w a s
matched to a single hair found 
on the accused’s boat.
A prominent civil-liberties lawyer
Barry Wilson has questioned the
indefinite retention of the 
samples, describing them as a
“blood bank of the nation’s chil-
dren”. Dianne Webster, manger of
the NTC said the samples were kept
for quality assurance purposes.
The Privacy Commissioner Bruce
Slane said he will hold an inquiry
that an inquiry into the issues 
surrounding the retention and use of
the blood samples, and the Health
and Disability Commissioner says
she will cooperate with investiga-
t i o n .
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Inmates in Irish prisons face drug abuse and disease
At least 20% of inmates in Irishprisons who inject drugs say they
began injecting while in custody,
according to a report by the
Department of Justice, Equality, and
Law Reform in Dublin, Ireland, on
Aug 19.
The report, conducted by the
Department of Community Health
and General Practice at Trinity
College, Dublin, was commissioned
to investigate the levels of HIV, 
hepatitis B, and hepatitis C in pris-
ons. The study involved nine institu-
tions and found that more than a
third of the prisoners had hepatitis C. 
Infection rates were highest among
drug abusing inmates: 19% had 
hepatitis B, 81% had hepatitis C, and
4% had HIV. Over half the respon-
dents reported opiate use and 43%,
60% of whom were women, said they
had injected drugs. According to the
report, drug abuse equipment was
shared by 58% of inmates injecting
drugs. Some prisoners said they did
not want to be tested for diseases
because they believed they would be
interrogated rather than counselled.
The Prison Service has welcomed
the report.
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